Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients

Name: Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients
Published: 2013
License: Public Domain

Leiden University Medical Center · 2013

ClinicalTrials.gov · Datasets · License: Public Domain · 2013

Open Source ↗

cardiovascular-disease fatty-liver magnetic-resonance-imaging metabolic-syndrome

diabetes mellitus type 2, metabolic syndrome, cardiovascular disease, diastolic dysfunction, fatty liver, glucagon-like peptide 1, magnetic resonance imaging, magnetic resonance spectroscopy, steatosis, interventional, phase4

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients

Related documents